oseltamivir has been researched along with g(m1) ganglioside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crain, SM; Shen, KF | 1 |
Chi, MH; Goleniewska, K; Higginbotham, JN; Moore, ML; O'Neal, JF; Peebles, RS; Zhou, W | 1 |
2 other study(ies) available for oseltamivir and g(m1) ganglioside
Article | Year |
---|---|
Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice.
Topics: Acetamides; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; G(M1) Ganglioside; Hyperalgesia; Male; Mice; Morphine; Neuraminidase; Neurons; Oseltamivir; Pain Measurement; Receptors, Opioid; Time Factors | 2004 |
Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.
Topics: Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Down-Regulation; Female; G(M1) Ganglioside; Immunity, Cellular; Lymphocyte Activation; Membrane Microdomains; Mice; Mice, Inbred BALB C; Neuraminidase; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Signal Transduction | 2007 |